Company | Name | Exchange | Sector | Industry | Analyst Recommendation | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kamada | NASDAQ | Healthcare | Pharmaceuticals | 1.5 | $383.56M | 26.5x | 0.43 | $6.68 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Iradimed Co | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.5 | $669.83M | 34.7x | 3.12 | $52.85 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.4% Upside | Upgrade to Pro+ | |
Addus | NASDAQ | Healthcare | Healthcare Providers & Services | 1.5 | $1.63B | 21.2x | 2.11 | $91.24 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Takeda Pharma ADR | NYSE | Healthcare | Pharmaceuticals | 1.5 | $47.77B | 34.4x | 2.18 | $15.13 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.7% Upside | Upgrade to Pro+ | |
Corcept | NASDAQ | Healthcare | Pharmaceuticals | 1.5 | $6.12B | 43.2x | 1.37 | $58 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
The Ensign | NASDAQ | Healthcare | Healthcare Providers & Services | 1.5 | $7.45B | 24.9x | 0.6 | $130.79 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
Auna ADR | NYSE | Healthcare | Healthcare Providers & Services | 1.5 | $527.77M | 15.4x | 0.13 | $7 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genfit | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.5 | $180.01M | 7.4x | 0.05 | $3.61 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.5 | $148.70B | 80.4x | 4.6 | $100.73 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.9% Upside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.54 | $44.97B | 44.1x | 9.35 | $90.87 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.5% Upside | Upgrade to Pro+ | |
Acadia Healthcare | NASDAQ | Healthcare | Healthcare Providers & Services | 1.54 | $2.72B | 10.5x | 0.01 | $29.26 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Integer Hld | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.56 | $4.05B | 34x | 1.29 | $120.62 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.2% Upside | Upgrade to Pro+ | |
Sanofi ADR | NASDAQ | Healthcare | Pharmaceuticals | 1.57 | $147.45B | 24.3x | 8.24 | $58.60 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.58 | $18.66B | 44.5x | 0.44 | $265.82 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Ardent Health Partners LLC | NYSE | Healthcare | Healthcare Providers & Services | 1.6 | $2.04B | 9.3x | 0.03 | $14.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.3% Upside | Upgrade to Pro+ | |
Protagonist Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.6 | $3.32B | 12.1x | 0.03 | $54.35 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.6% Upside | Upgrade to Pro+ | |
Merit | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.6 | $5.97B | 48.8x | 1.91 | $101.46 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Sensus Health | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.6 | $78.85M | 11.8x | 0.01 | $4.78 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurocrine | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.62 | $10.99B | 32.5x | 0.97 | $110.34 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.6% Upside | Upgrade to Pro+ | |
Tenet Healthcare | NYSE | Healthcare | Healthcare Providers & Services | 1.62 | $12.14B | 3.9x | 0.01 | $127.75 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.6% Upside | Upgrade to Pro+ | |
TG | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.63 | $6.16B | 260.3x | 3.73 | $42.49 | 6.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Labcorp Holdings | NYSE | Healthcare | Healthcare Providers & Services | 1.63 | $20.06B | 27x | 0.32 | $239.72 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.7% Upside | Upgrade to Pro+ | |
AstraZeneca ADR | NASDAQ | Healthcare | Pharmaceuticals | 1.64 | $237.71B | 33.8x | 1.89 | $76.33 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Eli Lilly | NYSE | Healthcare | Pharmaceuticals | 1.64 | $752.69B | 71.4x | 0.68 | $837.01 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.8% Upside | Upgrade to Pro+ | |
Biomarin Pharma | NASDAQ | Healthcare | Pharmaceuticals | 1.64 | $13.59B | 31.7x | 0.2 | $71.34 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.1% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.65 | $195.70B | 31.2x | 4.45 | $518.41 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.5% Upside | Upgrade to Pro+ | |
Jazz Pharma | NASDAQ | Healthcare | Pharmaceuticals | 1.65 | $8.61B | 15.6x | 0.36 | $142.07 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ | |
Sarepta | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.65 | $7.76B | 32.2x | 0.29 | $79.96 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IQVIA Holdings | NYSE | Healthcare | Biotechnology & Medical Research | 1.65 | $32.96B | 24.8x | 8.67 | $186.95 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.6% Upside | Upgrade to Pro+ | |
Harmony Bio | NASDAQ | Healthcare | Pharmaceuticals | 1.67 | $1.97B | 13.5x | 0.72 | $34.37 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.5% Upside | Upgrade to Pro+ | |
Ironwood | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.67 | $240.04M | 149x | 1.31 | $1.49 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aurinia Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.67 | $1.14B | 207.6x | 1.82 | $8.37 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.6% Upside | Upgrade to Pro+ | |
Elevance Health | NYSE | Healthcare | Healthcare Providers & Services | 1.68 | $97.95B | 16.7x | 8.77 | $430.59 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.71 | $66.56B | 39x | 0.91 | $231.85 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Zoetis Inc | NYSE | Healthcare | Pharmaceuticals | 1.75 | $73.34B | 29.9x | 3.68 | $163.77 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.6% Upside | Upgrade to Pro+ | |
Adapthealth | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.78 | $1.35B | 16x | 0.14 | $10.02 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.7% Upside | Upgrade to Pro+ | |
TransMedics | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.78 | $2.37B | 65.8x | 0.28 | $70.31 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Aurora Cannabis | NASDAQ | Healthcare | Pharmaceuticals | 1.8 | $239.02M | 68.1x | 0.19 | $4.34 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Collegium Pharmaceutical | NASDAQ | Healthcare | Pharmaceuticals | 1.8 | $936.69M | 13.9x | 0.31 | $29.85 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.8% Upside | Upgrade to Pro+ | |
HCA | NYSE | Healthcare | Healthcare Providers & Services | 1.8 | $82.47B | 15.1x | 0.86 | $334.18 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.2% Upside | Upgrade to Pro+ | |
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.81 | $221.35B | 16.6x | 0.12 | $127.42 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.9% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.82 | $37.71B | 19.7x | 0.44 | $82.39 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.3% Upside | Upgrade to Pro+ | |
Cardinal Health | NYSE | Healthcare | Pharmaceuticals | 1.82 | $31.88B | 24.4x | 0.26 | $132.13 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.3% Upside | Upgrade to Pro+ | |
Inspire Medical Systems | NYSE | Healthcare | Healthcare Equipment & Supplies | 1.82 | $4.83B | 91.1x | 0.26 | $162.65 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44% Upside | Upgrade to Pro+ | |
Regeneron Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.85 | $72.04B | 16.4x | 1.58 | $672.49 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 42.9% Upside | Upgrade to Pro+ | |
US Physicalrapy | NYSE | Healthcare | Healthcare Providers & Services | 1.86 | $1.15B | 41.4x | 0.95 | $76.04 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.7% Upside | Upgrade to Pro+ | |
Alkermes Plc | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.88 | $5.59B | 15.6x | 4.29 | $34.34 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.5% Upside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.89 | $16.02B | 38.4x | 0.94 | $80.12 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.4% Upside | Upgrade to Pro+ | |
Veracyte Inc | NASDAQ | Healthcare | Biotechnology & Medical Research | 1.91 | $2.49B | 102.9x | 0.78 | $31.78 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | |
LivaNova PLC | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 1.91 | $2.20B | 34.8x | 0.13 | $40.84 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.5% Upside | Upgrade to Pro+ |